JAIME COUTURE: Open Payments
NPI 1184107138 · PINE BLUFF, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 17 payments from 8 companies in 2025. Trend: 2023 $143 · 2024 $86 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Astellas Pharma US Inc | 2 | $50 |
| Novo Nordisk Inc | 3 | $45 |
| Dexcom, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: UBRELVY, SCEMBLIX, Veozah, Dexcom G6 Transmitter, MOUNJARO, BREZTRI, JARDIANCE, Wegovy.
Industry payments across AR — which companies pay providers there.
